Charles A. Deignan
Net Worth

Last updated:

What is Charles A. Deignan net worth?

The estimated net worth of Mr. Charles A. Deignan is at least $4,116,462 as of 19 Jan 2024. He owns shares worth $156,673 as insider, has earned $86,819 from insider trading and has received compensation worth at least $3,872,970 in Clearside Biomedical, Inc..

What is the salary of Charles A. Deignan?

Mr. Charles A. Deignan salary is $430,330 per year as Chief Financial Officer in Clearside Biomedical, Inc..

How old is Charles A. Deignan?

Mr. Charles A. Deignan is 61 years old, born in 1964.

What stocks does Charles A. Deignan currently own?

As insider, Mr. Charles A. Deignan owns shares in one company:

Company Title Shares Price per share Total value
Clearside Biomedical, Inc. (CLSD) Chief Financial Officer 384,662 $0.41 $156,673

What does Clearside Biomedical, Inc. do?

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

CLSD logo
CLSD
Clearside Biomedical, Inc.
$0.41

Charles A. Deignan insider trading

Clearside Biomedical, Inc.

Mr. Charles A. Deignan has made 7 insider trades between 2016-2024, according to the Form 4 filled with the SEC. Most recently he sold 12,900 units of CLSD stock worth $16,512 on 19 Jan 2024.

The largest trade he's ever made was exercising 34,090 units of CLSD stock on 13 Sep 2023. As of 19 Jan 2024 he still owns at least 384,662 units of CLSD stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 12,900 $1.28 $16,512
Option
Employee Stock Option (right to buy) 34,090 $0.4 $13,636
Option
Common Stock 34,090 $0.4 $13,636
Sale
Common Stock 14,030 $1.5 $21,045
Option
Employee Stock Option (right to buy) 23,636 $0.4 $9,454
Option
Common Stock 23,636 $0.4 $9,454
Sale
Common Stock 8,833 $2.09 $18,461
Sale
Common Stock 2,800 $6.41 $17,948
Sale
Common Stock 2,938 $4.37 $12,839
Sale
Common Stock 14,992 N/A N/A
Purchase
Common Stock 7,500 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 500 N/A N/A
Purchase
Common Stock 1,000 $7.07 $7,065
Sale
Common Stock 2 $7 $14

Clearside Biomedical key executives

Clearside Biomedical, Inc. executives and other stock owners filed with the SEC:

  • Dr. George M. Lasezkay Pharm.D., Pharma.D., J.D. (73) Pres, Chief Executive Officer & Director
  • Mr. Charles A. Deignan (61) Chief Financial Officer